100 Years of Biochemistry at the University of Toronto – Marian A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
PS CV Comp 050917
CURRICULUM VITAE NAME: Pamela Mary Stanley (nee Fetherstonhaugh) Lab Homepage http://www.einstein.yu.edu/departments/cellbiology/faculty/stanley/home/ NATIONALITY: Australian/American EDUCATION: l965-l967 Bachelor of Science University of Melbourne, Australia Majored in Biochemistry and Microbiology l968 B. Sc. Hons., Walter and Eliza Hall Institute, Melbourne, Australia Commonwealth Post-graduate Award Advisor: Gordon L. Ada Thesis: Tolerance to Foreign Erythrocytes Using Antigen-Containing Extracts of the Erythrocyte Membrane. l969-l972 Research for degree of Doctor of Philosophy in the Department of Microbiology, University of Melbourne, Australia Commonwealth Post-graduate Award Advisor: Professor David O. White Thesis: Influenza Virus Proteins l972-l975 Postdoctoral Fellow of the Medical Research Council of Canada in the Department of Medical Genetics, University of Toronto, Canada Advisor: Dr. Louis Siminovitch Postdoctoral Fellowship from the Medical Research Council of Canada Topic: The Isolation and Characterization of Lectin Resistant Chinese Hamster Ovary Cells. POSITIONS HELD: l976 Research Associate Department of Medical Genetics University of Toronto Toronto, Ontario, Canada l977-1982 Assistant Professor Dept. of Cell Biology Albert Einstein College of Medicine Bronx, New York 1982-1986 Associate Professor Dept. of Cell Biology Albert Einstein College of Medicine Bronx, New York 1986 Professor Department of Cell Biology Albert Einstein College of Medicine Bronx, New York 1994-2007 Director Training Program in Cell & Molecular Biology, Biochemistry & Genetics, NIGMS 1 1988-2012 Program leader Membrane Molecular Biology Albert Einstein Cancer Center 2002- Associate Director for Laboratory Research Albert Einstein NCI Cancer Center 2007- Horace W. Goldsmith Foundation Chair. HONORS: Dunlop Prize for First Place in Biochemistry (1966 and 1967) Aust. -
Installation of Professor Donald C. Ainslie
Installation of Professor Donald C. Ainslie Sixteenth PrinciPal of UniverSity college Installation of the Principal The audience will rise when the procession enters East Hall, led by bedel Victoria Hurlihey, President of the University College Alumni Association. Welcoming Remarks Cheryl Misak Vice-President & Provost, University of Toronto President’s Remarks Thursday, David Naylor December 1, 2011 at 3:10 p.m. President, University of Toronto University College, East Hall Oath of Office University of Toronto David Naylor Donald C. Ainslie Robing of the Principal Shelley Cornack Registrar, University College Gillian Einstein Professor of Psychology, University College David Rayside Professor of Political Science, University College Philip Sohm cover image: University Professor of Art & Vice-Principal, University College A Not Unsightly Building: University College and Its History by Douglas Richardson (page 140). Photograph by James A. Chalmers. Presentation of Greetings The Principals of University College Judy G. Goldring University College was established in 1853. Until 1901, Presidents of Vice-Chair, Governing Council the University of Toronto were also Presidents of University College. Meric Gertler 1853 – 1880 John McCaul Dean, Faculty of Arts & Science 1880 – 1892 Sir Daniel Wilson Anne Lancashire 1892 – 1901 James Loudon Professor of English, University College 1901 – 1928 Maurice Hutton Rose Wolfe 1928 – 1944 Malcolm William Wallace University College Distinguished Alumna & Chancellor Emerita, 1944 – 1945 Sidney Earle Smith University of Toronto 1945 – 1951 William Robert Taylor 1951 – 1959 Francois Charles Achille Jeanneret Michael Galang President, University College Literary & Athletic Society 1959 – 1963 Moffatt St. Andrew Woodside 1964 – 1970 Douglas Valentine LePan Introduction of the Principal 1970 – 1977 Archibald Cameron Hollis Hallett Cheryl Misak 1977 – 1989 George Peter Richardson Installation Address 1989 – 1997 Lynd Wilks Forguson Donald C. -
Student Events/Meetings
The University of British Columbia Senate & Curriculum Services www.senate.ubc.ca Okanagan Senate THE SEVENTH REGULAR MEETING OF THE OKANAGAN SENATE FOR THE 2012/2013 ACADEMIC YEAR WEDNESDAY, 27 MARCH 2013 3:30 P.M. to 5:30 P.M. ASC 130 | OKANAGAN CAMPUS 1. Minutes of the Meeting of 27 February 2013 – Prof. Stephen J. Toope (approval) (master pages 2-15) 2. Business Arising from the Minutes 3. President’s Remarks – Prof. Stephen J. Toope (information) (master pages 16-35) Record of President’s Activities for 11 November 2012 to 8 March 2013 4. Certificates of Appreciation for Student Senators Completing their Terms on 31 March 2013 – Prof. Stephen J. Toope (information) 5. Deputy Vice-Chancellor’s Remarks – Prof. Deborah Buszard (information) (master pages 36-37) Record of Deputy Vice-Chancellor’s Activities for 1 January 2013 to 15 March 2013 6. Admissions and Awards Committee – Dr Spiro Yannacopoulos (approval) (master pages 38-39) New and Revised Awards 7. Curriculum Committee – Dr Dwayne Tannant (approval) (master pages 40-68) March Curriculum Report 8. Nominating Committee – Mr Curtis Tse (approval) (master pages 69-70) Appointments to Okanagan Master Plan Steering Committee 9. Other Business Regrets: Kevin Harding, telephone 604.827.1774 or e-mail: [email protected] UBC Senates and Council of Senate website: http://www.senate.ubc.ca Okanagan Senate www.senate.ubc.ca Okanagan Senate Minutes of 27 February 2013 DRAFT Attendance Present: Prof. D. Buszard (Vice-Chair); Ms. L.M. Collins (Secretary); Mr R. Adl; Dr P. Arthur; Mr K. Aziz; Ms S. Baez; Mr J. -
GLYCO 21 XXI International Symposium on Glycoconjugates
GLYCO 21 XXI International Symposium on Glycoconjugates Abstracts August 21-26, 2011 Vienna, Austria Glycoconj J (2011) 28: 197–36 9 Organising Committee Erika Staudacher (Austria) Leopold März (Austria) Günter Allmaier (Austria) Lothar Brecker (Austria) Josef Glössl (Austria) Hanspeter Kählig (Austria) Paul Kosma (Austria) Lukas Mach (Austria) Paul Messner (Austria) Walther Schmid (Austria) Igor Tvaroška (Slovakia) Reinhard Vlasak (Austria) Iain Wilson (Austria) Scientifi c Program Committee Iain Wilson (Austria) Paul Messner (Austria) Günter Allmaier (Austria) Reginald Bittner (Austria) Paul Kosma (Austria) Eva Stöger (Austria) Graham Warren (Austria) John Hanover (USA; nominated by the Society for Glycobiology) Kelly ten Hagen (USA; nominated by the Society for Glycobiology) supported in abstract selection by Michael Duchêne (Austria) Catherine Merry (UK) Tadashi Suzuki (Japan) Abstracts of the 21st International Symposium on Glycoconjugates The International Glycoconjugate Organisation Gerald W. Hart, President Leopold März, President-elect Paul Gleeson, Immediate Past-president Sandro Sonnino, Secretary Thierry Hennet, Treasurer National Representatives Pedro Bonay (Spain) to replace Angelo Reglero Nicolai Bovin (Russia) Jin Won Cho (Korea) Henrik Clausen (Denmark) Anne Dell (UK) Jukka Finne (Finland) Paul Gleeson (Australia) Jianxin Gu (China) Gerald Hart (USA) Thierry Hennet (Switzerland) Jim Jamieson (Canada) Gordan Lauc (Croatia) Hakon Leffl er (Sweden) Jean-Claude Michalski (France) Werner Reutter (Germany) Sandro Sonnino (Italy) Avadhesha Surolia (India) Ken Kitajima (Japan) Maciej Ugorski (Poland) Johannes F.G. Vliegenthart (The Netherlands) Iain Wilson (Austria) to replace Leopold März Albert M. Wu (Taiwan) Lode Wyns (Belgium) Yehiel Zick (Israel) Glycoconj J (2011) 28: 197–369 Past Presidents Eugene. A. Davidson (USA) Alan B. Foster (UK) Paul Gleeson (Australia) Mary Catherine Glick (USA) Colin Hughes (UK) Roger W. -
The Complex Life of the Complex Life Of
The Complex Life of mRNA EMBO|EMBL Symposium 5–8 October 2016 Heidelberg | Germany EMBL Advanced Training Centre KEYNOTE SPEAKERS Thomas Cech Patrick Cramer Jennifer Doudna University of Colorado Boulder, USA MPI for Biophysical Chemistry, Germany University of California, Berkley, USA ABSTRACT SUBMISSION DEADLINE CONFIRMED SPEAKERS 13 JULY 2016 Maria Barna Rachel Green Shona Murphy Stanford University, USA Johns Hopkins University Sir William Dunn School of Pathology, UK School of Medicine, USA REGISTRATION DEADLINE Simon Bullock Karla Neugebauer 24 AUGUST 2016 MRC Laboratory of Molecular Biology, UK Chuan He Yale University, USA The University of Chicago, USA Emmanuelle Charpentier Uwe Ohler MPI for Infection Biology, Germany Alan Hinnebusch Max Delbrueck Center, Berlin, Germany ORGANISERS NIH, USA Anne Ephrussi Jeffrey Chao Laura Ranum EMBL Heidelberg, Germany Friedrich Miescher Institute for Elisa Izaurralde University of Florida, USA Biomedical Research, Switzerland MPI for Developmental Biology, Germany Nahum Sonenberg Erin Schuman McGill University, Canada Elena Conti Jeff Kieft MPI for Brain Research, Germany MPI of Biochemistry, Germany University of Colorado, USA Joan Steitz Yukihide Tomari Yale University, USA Victoria D'Souza Iain MacRae The University of Tokyo, Japan Harvard University, USA The Scripps Research Institute, USA David Tollervey Jonathan Weissman Wellcome Trust Centre for Cell Biology, UK Caroline Dean James Manley University of California, John Innes Centre, UK Columbia University, USA San Francisco, USA Additional speakers will be Gideon Dreyfuss Christine Mayr Marat Yusupov selected from abstracts. Perelman School of Medicine at the Memorial Sloan Kettering Cancer Institute of Genetics and Molecular University of Pennsylvania, USA Center, USA and Cellular Biology (IGBMC), France CONTACT www.embo-embl-symposia.org [email protected]. -
Profile of Nahum Sonenberg PROFILE Ann Griswold, Science Writer
PROFILE Profile of Nahum Sonenberg PROFILE Ann Griswold, Science Writer Five years after the final shots of World War II rang out, a child and his father stood on the coast of the Mediterranean Sea. From their vantage point in a cemetery in the town of Jaffa, Israel, the boy gazed across the sea and envisioned stepping onto the sands of a distant shore. He pointed to the horizon and asked his father what lay beyond. “I remember my father said, ‘There is America, the country where everything is possible,’” says Nahum Sonenberg, the Gilman Cheney Professor of Biochem- istry at McGill University in Montreal. Sonenberg, elected as a foreign associate to the National Academy of Sciences in 2015, has spent nearly five decades looking beyond the horizon to map un- explored territory in molecular biology. His research has uncovered the cellular control knobs of protein synthesis and revealed how this process drifts off-course in cancer, obesity, diabetes, and neurological diseases. His achievements have garnered numerous hon- ors. Sonenberg is a fellow of the Royal Society of London and Canada, Foreign Member of the Amer- ican Academy of Arts and Sciences and the American Association for the Advancement of Science, Asso- ciate Member of European Molecular Biology Orga- nization, and an Officer of the Order of Canada. He has received numerous prizes in the biological sciences, including the Lewis S. Rosenstiel Award for Distin- guished Work in Basic Medical Science, the Wolf Prize, and the Gairdner Foundation International Award. Nahum Sonenberg. Image courtesy of Howard Hughes Medical Institute. Life in Transition Sonenberg’s childhood unfolded in the aftermath of By the time Sonenberg turned 10, he and his family had World War II. -
Carbohydrate-De¢Cient Glycoprotein Syndrome Type II
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1455 (1999) 179^192 www.elsevier.com/locate/bba Review Carbohydrate-de¢cient glycoprotein syndrome type II Harry Schachter a;*, Jaak Jaeken b a Department of Biochemistry, University of Toronto Medical School, and Department of Structural Biology and Biochemistry, Hospital for Sick Children, 555 University Avenue, Toronto, Ont. M5G 1X8, Canada b Center for Metabolic Disease, University of Leuven, Leuven, Belgium Received 8 February 1999; accepted 3 May 1999 Abstract The carbohydrate-deficient glycoprotein syndromes (CDGS) are a group of autosomal recessive multisystemic diseases characterized by defective glycosylation of N-glycans. This review describes recent findings on two patients with CDGS type II. In contrast to CDGS type I, the type II patients show a more severe psychomotor retardation, no peripheral neuropathy and a normal cerebellum. The CDGS type II serum transferrin isoelectric focusing pattern shows a large amount (95%) of disialotransferrin in which each of the two glycosylation sites is occupied by a truncated monosialo-monoantennary N-glycan. Fine structure analysis of this glycan suggested a defect in the Golgi enzyme UDP-GlcNAc:K-6-D-mannoside L-1,2-N-acetylglucosaminyltransferase II (GnT II; EC 2.4.1.143) which catalyzes an essential step in the biosynthetic pathway leading from hybrid to complex N-glycans. GnT II activity is reduced by over 98% in fibroblast and mononuclear cell extracts from the CDGS type II patients. Direct sequencing of the GnT II coding region from the two patients identified two point mutations in the catalytic domain of GnT II, S290F (TCC to TTC) and H262R (CAC to CGC). -
Bulletin the Canadian Society for Molecular Biosciences La Société Canadienne Pour Les Biosciences Moléculaires
Bulletin The Canadian Society for Molecular Biosciences La Société Canadienne pour les Biosciences Moléculaires 2018 www.csmb-scbm.ca Bulletin The Canadian Society for Molecular Biosciences La Société Canadienne pour les Biosciences Moléculaires 2018www.csmb-scbm.ca CSMB | SCBM Bulletin 2018 1 Table of Contents CSMB Board for 2018 ......................................................................................................................................4 President’s Report 2018 ..................................................................................................................................6 Incoming Members of the Executive Board ...................................................................................................9 Imogen Coe, Vice-President .................................................................................................................9 Walid Houry, Councillor .....................................................................................................................10 Minutes of the 61st Annual General Meeting 2018 ..................................... ...............................................11 Financial Statement 2018 .............................................................................................................................14 61st Annual Meeting, Banff, Alberta ............................................................................................................19 Meeting Report: “Membrane Proteins in Health and Disease” .........................................................19 -
Record of the President's Activities from 16 August to 31 October 2010
Vancouver Senate 15 Dec 2010 Item 4a p.1 Record of President’s Activities Period of: 16 August 2010 to 31 October 2010 External Group August 16 David McLean, Chairman, Canadian National Railway Company, Chairman and CEO, McLean Group of Companies August 16 Paul Davidson, President and CEO, and Pari Johnston, Director, International Relations, Secretary, Association of Universities and Colleges of Canada (AUCC) August 16 Djavad Mowafaghian, Founder and Honourary President, Vahid Eshghi, Director, and Margaret Thomson, Treasurer and Trustee, djavad mowafaghian foundation August 16 Marjorie-Anne Sauder, Donor, UBC August 17 Jay L. Bruns III, Vice President, Public Policy, The Hartford August 17 Lisa Kershaw, Partner, Odgers Berndtson August 17 Kevin Layden, President and CEO, Wesbild Holdings Ltd. August 18 Robert Ho, Founder, Robert H.N. Ho Family Foundation and President, The Tung Lin Kok Yuen Canada Foundation August 18 Matthew Carter, President, Greater Northern Way Campus (GNWC) August 18 Lee Malleau, Acting CEO, Vancouver Economic Development Commission, Saeed Amidi, President and CEO, Gord Breese, Vice President, Business Management Software Solutions Applications and Services (SAP), JoJo Flores, Co-Founder and VP Operations, Plug and Play Inc., Sandhu Johnston, Deputy City Manager, City of Vancouver, and Linda Oglov, Consultant to the City of Vancouver August 19 UBC Properties Trust (UBCPT) Board Meeting August 19 Arvind Gupta, CEO and Scientific Director, Mathematics of Information Technology and Complex Systems (MITACS) August -
Biography: David Naylor
Biography: David Naylor ● President, University of Toronto, since October 1, 2005. ● Dean of Medicine and Vice Provost, Relations with Health Care Institutions, at the University of Toronto since 1999. As dean, academic and administrative leadership role in Canada's largest multi-disciplinary health science faculty (2,000 full-time academic appointees). As Vice Provost, responsible for relations with nine fully-affiliated and eleven partly-affiliated hospitals. Also facilitated partnerships with various community and governmental partners. ● Formerly a Senior Scientist of the Medical Research Council of Canada (MRC), co-author of approximately 300 scholarly publications. Scholarly work spans social history, public policy, epidemiology and biostatistics, and health economics, as well as clinical and health services research in most fields of medicine. ● MD with honours from the University of Toronto in 1978 with scholarships in medicine, surgery and paediatrics. ● Rhodes Scholar, 1979 at Hertford College, Oxford University. Earned D.Phil. in 1983, for thesis work in the Sub-Faculty of Sociology, Department of Social and Administrative Studies. ● Trained in general internal medicine at the University of Western Ontario (Fellow of the Royal College of Physicians and Surgeons of Canada, 1986), followed by a year in Toronto as an MRC fellow in clinical epidemiology. ● Joined the academic staff of the Faculty of Medicine at the University of Toronto in 1987-88. ● From 1990 to 1996 developed and led a new research program in clinical epidemiology at Sunnybrook Health Science Centre in Toronto. ● From 1991 to 1998 developed, and was inaugural Chief Executive Officer of, the Institute for Clinical Evaluative Sciences (ICES), a non-profit corporation that continues to support Canada's largest multi-disciplinary grouping of academics and trainees dedicated to healthcare research. -
The Magic Is the Protein.’’ Don’T Wait a Lifetime for a Decision
Vol. 19 / No. 4 / April 2020 THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY ‘‘ The magic isn’t the squid… The magic is the protein.’’ Don’t wait a lifetime for a decision. C. elegans daf-2 mutants can live up to 40 days. JBC takes only 17 days on average to reach a fi rst decision about your paper. Learn more about fast, rigorous review at jbc.org. www.jbc.org NEWS FEATURES PERSPECTIVES 2 22 37 EDITOR’S NOTE ‘THE MAGIC ISN’T THE SQUID ... USE THE MIC! Caution: Tchotchkes at work The magic is the protein.’ 38 3 28 WHAT CAN YOUR OMBUDS OFFICE MEMBER UPDATE ‘START SIMPLE. IT ALWAYS GETS DO FOR YOU? MORE COMPLICATED.’ 6 A conversation with Paul Dawson IN MEMORIAM 10 ANNUAL MEETING RETROSPECTIVE Marilyn Farquhar (1928 – 2019) 32 MOLECULAR & CELLULAR PROTEOMICS SESSION 13 LIPID NEWS 32 A deeper insight into phospholipid MCP TO HOST PROTEOMICS SESSION biosynthesis in Gram-positive bacteria 33 GINGRAS STUDIES PROTEOMICS’ IMPLICATIONS FOR RESEARCH 14 34 JOURNAL NEWS SELBACH SEEKS THE SCIENCE BEHIND THE MAGIC 14 Scrutinizing pigs’ biggest threat 35 15 Progesterone from an unexpected source GARCIA USES MASS SPECTRONOMY TO UNRAVEL THE HUMAN EPIGENOME may affect miscarriage risk 16 Finding neoantigens faster — advances in the study of the immunopeptidome Don’t wait a lifetime for a decision. 18 From the journals C. elegans daf-2 mutants can live up to 40 days. JBC takes only 17 days on average to reach a fi rst decision about your paper. Learn more about fast, rigorous review at jbc.org. -
''Glycosylation Diseases: Quo Vadis?''
”Glycosylation diseases: Quo vadis?” Harry Schachter, Hudson Freeze To cite this version: Harry Schachter, Hudson Freeze. ”Glycosylation diseases: Quo vadis?”. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2009, 1792 (9), pp.925. 10.1016/j.bbadis.2008.11.002. hal-00562879 HAL Id: hal-00562879 https://hal.archives-ouvertes.fr/hal-00562879 Submitted on 4 Feb 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ÔØ ÅÒÙ×Ö ÔØ ”Glycosylation diseases: Quo vadis?” Harry Schachter, Hudson Freeze PII: S0925-4439(08)00227-5 DOI: doi: 10.1016/j.bbadis.2008.11.002 Reference: BBADIS 62892 To appear in: BBA - Molecular Basis of Disease Received date: 11 September 2008 Revised date: 3 November 2008 Accepted date: 6 November 2008 Please cite this article as: Harry Schachter, Hudson Freeze, ”Glycosylation diseases: Quo vadis?”, BBA - Molecular Basis of Disease (2008), doi: 10.1016/j.bbadis.2008.11.002 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.